Home/Filings/4/0000950170-25-009239
4//SEC Filing

Maniar Shweta 4

Accession 0000950170-25-009239

CIK 0001111485other

Filed

Jan 26, 7:00 PM ET

Accepted

Jan 27, 4:40 PM ET

Size

5.1 KB

Accession

0000950170-25-009239

Insider Transaction Report

Form 4
Period: 2025-01-22
Transactions
  • Sale

    Common Stock

    2025-01-22$30.87/sh3,519$108,6187,383 total
Footnotes (2)
  • [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan established on August 22, 2024 by the Reporting Person.
  • [F2]Represents the weighted average share price of an aggregate total of 3,519 shares sold in the price range of $30.5166 to $31.26 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Documents

1 file

Issuer

RxSight, Inc.

CIK 0001111485

Entity typeother

Related Parties

1
  • filerCIK 0001850826

Filing Metadata

Form type
4
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 4:40 PM ET
Size
5.1 KB